[go: up one dir, main page]

TWI264434B - New mandelic acid derivatives and their use as thrombin inhibitors - Google Patents

New mandelic acid derivatives and their use as thrombin inhibitors

Info

Publication number
TWI264434B
TWI264434B TW91132920A TW91132920A TWI264434B TW I264434 B TWI264434 B TW I264434B TW 91132920 A TW91132920 A TW 91132920A TW 91132920 A TW91132920 A TW 91132920A TW I264434 B TWI264434 B TW I264434B
Authority
TW
Taiwan
Prior art keywords
acid derivatives
mandelic acid
thrombin inhibitors
thrombin
new
Prior art date
Application number
TW91132920A
Other languages
Chinese (zh)
Other versions
TW200306975A (en
Inventor
Tord Inghardt
Anders Johansson
Arne Svensson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to TW91132920A priority Critical patent/TWI264434B/en
Publication of TW200306975A publication Critical patent/TW200306975A/en
Application granted granted Critical
Publication of TWI264434B publication Critical patent/TWI264434B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

There is provided a compound of formula I, wherein Ra, R1, R2, Y and R3 have meanings given in the description and pharmaceutically-acceptable derivatives (including prodrugs) thereof, which compounds and derivatives are useful as, or are useful as prodrugs of, competitive inhibitors of trypsin-like proteases, such as thrombin, and thus, in particular, in the treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants.
TW91132920A 2001-11-26 2002-11-08 New mandelic acid derivatives and their use as thrombin inhibitors TWI264434B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW91132920A TWI264434B (en) 2001-11-26 2002-11-08 New mandelic acid derivatives and their use as thrombin inhibitors

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TW90129207 2001-11-26
TW91132920A TWI264434B (en) 2001-11-26 2002-11-08 New mandelic acid derivatives and their use as thrombin inhibitors

Publications (2)

Publication Number Publication Date
TW200306975A TW200306975A (en) 2003-12-01
TWI264434B true TWI264434B (en) 2006-10-21

Family

ID=37969346

Family Applications (1)

Application Number Title Priority Date Filing Date
TW91132920A TWI264434B (en) 2001-11-26 2002-11-08 New mandelic acid derivatives and their use as thrombin inhibitors

Country Status (1)

Country Link
TW (1) TWI264434B (en)

Also Published As

Publication number Publication date
TW200306975A (en) 2003-12-01

Similar Documents

Publication Publication Date Title
MY136133A (en) New mandelic acid derivatives and their use as thrombin inhibitors
MX9804623A (en) Prodrugs of thrombin inhibitors.
SE9602646D0 (en) Pharmaceutically useful compounds
SE9602263D0 (en) New amino acid derivatives
MX9800146A (en) New thrombin inhibitors, their preparation and use.
IS5511A (en) New compounds
CY1107149T1 (en) New amidinobenzylamine derivatives and their use as thrombin inhibitors
NO20012914D0 (en) Novel amidino derivatives and their use as thrombin inhibitors
SE0001803D0 (en) New compounds i
MY132033A (en) New mandelic acid derivatives and their use as thrombin inhibitors
MY133333A (en) New salts
NO20030675D0 (en) Novel amidino derivatives and their use as thrombin inhibitors
PL369325A1 (en) New mandelic acid derivatives and their use as thrombin inhibitors
TWI264434B (en) New mandelic acid derivatives and their use as thrombin inhibitors
TH36520A (en) New amidino derivatives and their use as thrombin inhibitors
WO2005058826A8 (en) New 5,6-dihydropyrin-2-one compounds useful as inhibitors of thrombin

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees